Skip to main content
Figure 2 | Arthritis Research & Therapy

Figure 2

From: Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study

Figure 2

Frequency of individual components of the metabolic syndrome (NCEP 2004) among patients taking methotrexate and not taking methotrexate. * P < 0.05. BP = blood pressure; FPGM = fasting plasma glucose > 5.6 mmol/L; HDL = high density lipoproteins; NCEP = National Cholesterol Education programme; TG = triglycerides.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us